Caliper Technologies Corp., SmithKline Beecham deal

Under CALP's Applications Developer Program, the companies will develop tools and methods for performing chemical synthesis for medicinal chemistry and lead discovery using CALP's LabChip microfluidic chip technology. CALP will provide microfluidics instrumentation, training and custom chips capable of performing SB's synthetic chemistry assays. The companies will share rights to any microfluidics technology or chips developed under the alliance. ...